...
首页> 外文期刊>Biochimica et biophysica acta. Molecular basis of disease: BBA >Downregulation of Metallothionein 1F, a putative oncosuppressor, by loss of heterozygosity in colon cancer tissue
【24h】

Downregulation of Metallothionein 1F, a putative oncosuppressor, by loss of heterozygosity in colon cancer tissue

机译:通过失去结肠癌组织中的杂合性,下调金属硫蛋白1F(一种推定的抑癌药)

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose: Downregulation of metallothionein (MT) genes has been reported in several tumors with discrepant results. This study is to investigate molecular mechanism of MT gene regulation in colon cancer which is characterized by tumor suppressor gene alterations. Experimental design: Integral analysis of microarray data with loss of heterozygosity (LOH) information was employed. Quantitative real-time PCR and immunohistochemistry were used to validate MT isoform expression in colon cancer tissues and cell lines. The effects of MT1F expression on RKO cell survival and tumorigenesis was analyzed. Bisulphite sequencing PCR (BSP) and methylation-specific PCR were employed to detect the methylation status of the MT1F gene in colon cancer tissues and cell lines. DNA sequencing was used to examine the LOH at the MT1F locus. Results: MT1F, MT1G, MT1X, and MT2A gene expression was significantly downregulated in colon cancer tissue (p< 0.05). Exogenous MT1F expression increased RKO cell apoptosis and inhibited RKO cell migration, invasion and adhesion as well as in vivo tumorigenicity. Downregulation of MT1F gene in majority of human colon tumor tissues is mainly through mechanism by loss of heterozygosity (p= 0.001) while CpG island methylation of MT1F gene promoter region was only observed in poorly differentiated, MSI-positive RKO and LoVo colon cancer cell lines. Conclusions: MT1F is a putative tumor suppressor gene in colon carcinogenesis that is downregulated mainly by LOH in colon cancer tissue. Further studies are required to elucidate a possible role for MT1F downregulation in colon cancer initiation and/or progression.
机译:目的:已经报道了几种肿瘤中金属硫蛋白(MT)基因的下调,结果不一致。本研究旨在探讨以肿瘤抑制基因改变为特征的结肠癌MT基因调控的分子机制。实验设计:使用具有杂合性(LOH)信息丢失的微阵列数据的整体分析。实时定量PCR和免疫组织化学用于验证结肠癌组织和细胞系中MT亚型的表达。分析了MT1F表达对RKO细胞存活和肿瘤发生的影响。亚硫酸氢盐测序PCR(BSP)和甲基化特异性PCR用于检测结肠癌组织和细胞系中MT1F基因的甲基化状态。 DNA测序用于检查MT1F基因座处的LOH。结果:结肠癌组织中的MT1F,MT1G,MT1X和MT2A基因表达显着下调(p <0.05)。外源MT1F表达增加RKO细胞凋亡并抑制RKO细胞迁移,侵袭和粘附以及体内致瘤性。大多数人类结肠肿瘤组织中MT1F基因的下调主要是通过杂合性丧失(p = 0.001)引起的,而MT1F基因启动子区域的CpG岛甲基化仅在低分化,MSI阳性的RKO和LoVo结肠癌细胞系中观察到。 。结论:MT1F是结肠癌发生中的一种抑癌基因,在结肠癌组织中主要受LOH的抑制。需要进一步的研究来阐明MT1F下调在结肠癌的发生和发展中的可能作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号